Evidence map›Paper›PMID 15377394›Full record

Trial reportRespiratory research2004

Safety assessment of inhaled xylitol in mice and healthy volunteers.

Lakshmi Durairaj, Janice Launspach, Janet L Watt, Thomas R Businga, Joel N Kline, Peter S Thorne, Joseph Zabner

2 registry-linked trialsOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in Respiratory research, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00928135 phase1 / phase2completednot on this mapstarted 2013, after this paper: background citation

Randomized Controlled Study of Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Hospitalized Patients With Exacerbation of Cystic Fibrosis

TypeinterventionalSponsorJoseph ZabnerRan2013 to 2018Enrolled63ConditionsCystic FibrosisArmsXylitol, Hypertonic saline
NCT01355796 phase1 / phase2completednot on this mapstarted 2011, after this paper: background citation

Randomized Cross Over Study of Inhaled Hypertonic Xylitol Versus Hypertonic Saline in Stable Subjects With Cystic Fibrosis

TypeinterventionalSponsorJoseph ZabnerRan2011 to 2015Enrolled30ConditionsCystic FibrosisArmsXylitol, Hypertonic saline
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Neonates with cystic fibrosis have a reduced nasal liquid pH; a small pilot study.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2014
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lakshmi DurairajDepartment of Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA. lakshmi-durairaj@uiowa.edu <lakshmi-durairaj@uiowa.edu>
Janice Launspach
Janet L Watt
Thomas R Businga
Joel N Kline
Peter S Thorne
Joseph Zabner
University of Iowa · US

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Alejandro Antonio Pezzulo · 1998 to 2026
$30.5M
XANTHINE OXIDASE PRODUCTS IN MODULATION OF ENDOTHELIAL DYSFUNCTIONM01RR000059 · NCRR · UNIVERSITY OF IOWA · PI ASHARE, ALIX · 1985 to 2007
$22.3M
Xylitol Enhancement of Bacterial Killing by AirwayP50HL061234 · NHLBI · UNIVERSITY OF IOWA · PI ZABNER, JOSEPH · 1998 to 2007
$13.6M
NCRR NIH HHS M01 RR000059NCRR NIH HHS RR00059NHLBI NIH HHS HL61234-06NHLBI NIH HHS P50 HL061234NIDDK NIH HHS DK54759NIDDK NIH HHS P30 DK054759NIEHS NIH HHS P30 ES005605NIEHS NIH HHS P30 ES 05605
6 · The paper itself

Abstract

backgroundXylitol is a 5-carbon sugar that can lower the airway surface salt concentration, thus enhancing innate immunity. We tested the safety and tolerability of aerosolized iso-osmotic xylitol in mice and human volunteers.

methodsThis was a prospective cohort study of C57Bl/6 mice in an animal laboratory and healthy human volunteers at the clinical research center of a university hospital. Mice underwent a baseline methacholine challenge, exposure to either aerosolized saline or xylitol (5% solution) for 150 minutes and then a follow-up methacholine challenge. The saline and xylitol exposures were repeated after eosinophilic airway inflammation was induced by sensitization and inhalational challenge to ovalbumin. Normal human volunteers underwent exposures to aerosolized saline (10 ml) and xylitol, with spirometry performed at baseline and after inhalation of 1, 5, and 10 ml. Serum osmolarity and electrolytes were measured at baseline and after the last exposure. A respiratory symptom questionnaire was administered at baseline, after the last exposure, and five days after exposure. In another group of normal volunteers, bronchoalveolar lavage (BAL) was done 20 minutes and 3 hours after aerosolized xylitol exposure for levels of inflammatory markers.

resultsIn naive mice, methacholine responsiveness was unchanged after exposures to xylitol compared to inhaled saline (p = 0.49). There was no significant increase in Penh in antigen-challenged mice after xylitol exposure (p = 0.38). There was no change in airway cellular response after xylitol exposure in naive and antigen-challenged mice. In normal volunteers, there was no change in FEV1 after xylitol exposures compared with baseline as well as normal saline exposure (p = 0.19). Safety laboratory values were also unchanged. The only adverse effect reported was stuffy nose by half of the subjects during the 10 ml xylitol exposure, which promptly resolved after exposure completion. BAL cytokine levels were below the detection limits after xylitol exposure in normal volunteers.

conclusionsInhalation of aerosolized iso-osmotic xylitol was well-tolerated by naive and atopic mice, and by healthy human volunteers.

Indexed as

Administration, InhalationAdultAirway ResistanceAnimalsCohort StudiesFemaleHumansLungMaleMiceMice, Inbred C57BLReference ValuesXylitolXylitol

Identifiers

PMID15377394
PMCPMC521689
OpenAlexW2161788120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.